Inmedical Therapeutics develops Covergel, a specialized gel designed to enhance visibility and reduce complications during therapeutic endoscopies. This product addresses the challenges of fluid management and tissue adherence, improving procedural outcomes for healthcare providers.
Funding
$870.8K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Therapeutic endoscopies often suffer from poor visualization due to fluid accumulation and tissue adherence, which can complicate procedures and negatively impact patient outcomes. Maintaining a clear field of view during these delicate interventions is crucial for effective treatment.
Solution
Inmedical Therapeutics offers Covergel, a specialized gel designed to improve visualization and minimize complications during therapeutic endoscopic procedures. Covergel addresses the challenges of fluid management by creating a protective barrier that prevents fluid accumulation on the lens. Additionally, its unique formulation reduces tissue adherence, ensuring a clear and unobstructed view of the target area. By enhancing visibility, Covergel facilitates more precise and efficient endoscopic interventions, ultimately leading to improved procedural outcomes for healthcare providers and patients.
Target Audience
The primary users are healthcare providers, specifically gastroenterologists and other specialists who perform therapeutic endoscopic procedures.
Features
- Specialized gel formulation for enhanced visualization during therapeutic endoscopies
- Creates a protective barrier to prevent fluid accumulation on the lens
- Reduces tissue adherence for a clear and unobstructed view
- Improves procedural efficiency and precision